Intel Inc. (NASDAQ: INTC): Roth downgraded its rating on the company to Neutral from Buy.
Tenet Healthcare Corp. (NYSE: THC): Jefferies & Co. initiated its coverage on the company with a Buy rating and a price target of $9.50. In a research note to clients, the firm wrote that checks indicate FY11 PC growth will be about 5% vs. Intel's 10%-12% assumptions. Additionally, the analyst believes ARM Holdings (ARMH) will become a bigger threat longer-term and constrain Intel's multiple.
Textron (NYSE: TXT): Deutsche Bank lowered its rating on the stock to Hold from Buy.
Nabors Industries (NYSE: NBR): Global Hunter this morning downgraded its rating on the company to Accumulate from Buy. However, the firm raised its price target pon the stock to $41 from $34.
Identive Group (NASDAQ: INVE): BofA/Merrill on Thursday downgraded its rating on the company to Neutral from Buy.
Full Disclosure: None.
